- Home
- TGS vs ACLX Comparison
TGS vs ACLX Comparison
Compare TGS & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TGS
- ACLX
- Stock Information
- Founded
- TGS 1992
- ACLX 2015
- Country
- TGS Argentina
- ACLX United States
- Employees
- TGS N/A
- ACLX N/A
- Industry
- TGS Natural Gas Distribution
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- TGS Utilities
- ACLX Health Care
- Exchange
- TGS Nasdaq
- ACLX Nasdaq
- Market Cap
- TGS 4.4B
- ACLX 4.1B
- IPO Year
- TGS N/A
- ACLX 2022
- Fundamental
- Price
- TGS $22.07
- ACLX $76.42
- Analyst Decision
- TGS Strong Buy
- ACLX Strong Buy
- Analyst Count
- TGS 1
- ACLX 13
- Target Price
- TGS $40.00
- ACLX $114.75
- AVG Volume (30 Days)
- TGS 663.0K
- ACLX 507.4K
- Earning Date
- TGS 11-03-2025
- ACLX 11-06-2025
- Dividend Yield
- TGS 4.20%
- ACLX N/A
- EPS Growth
- TGS 69.56
- ACLX N/A
- EPS
- TGS 0.35
- ACLX N/A
- Revenue
- TGS $1,027,524,722.00
- ACLX $56,979,000.00
- Revenue This Year
- TGS N/A
- ACLX N/A
- Revenue Next Year
- TGS N/A
- ACLX $174.18
- P/E Ratio
- TGS $12.86
- ACLX N/A
- Revenue Growth
- TGS 2.37
- ACLX N/A
- 52 Week Low
- TGS $18.15
- ACLX $47.86
- 52 Week High
- TGS $34.37
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- TGS 37.64
- ACLX 61.10
- Support Level
- TGS $21.01
- ACLX $73.16
- Resistance Level
- TGS $24.01
- ACLX $78.61
- Average True Range (ATR)
- TGS 1.30
- ACLX 2.84
- MACD
- TGS -0.35
- ACLX 0.55
- Stochastic Oscillator
- TGS 20.53
- ACLX 75.42
About TGS Transportadora de Gas del Sur SA TGS
Transportadora de Gas del Sur SA is a transporters of natural gas in Latin America. The company's operating segments include Natural Gas Transportation, Midstream, Telecommunications, Production and Commercialization Liquids, Other Services, and Telecommunications. It generates maximum revenue from the Production and Commercialization of the Liquids segment. Geographically, it derives the majority of its revenue from Argentina.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.